Impact of pharmacist-led care on glycaemic control of patients with uncontrolled type 2 diabetes: a randomised controlled trial in Nigeria

Simple item page
dc.contributor.authorSOREMEKUN, Rebecca O.
dc.contributor.authorABAH, Isaac O.
dc.contributor.authorDAVID, Emmanuel A
dc.date.accessioned2023-05-08T16:54:52Z
dc.date.available2023-05-08T16:54:52Z
dc.date.issued2021-08-14
dc.description.abstractBackground: Diabetes mellitus is a chronic, degenerative disease, requiring a multi-dimensional, multi-professional care by healthcare providers and substantial self-care by the patients, to achieve treatment goals. Objective: To evaluate the impact of pharmacist-led care on glycaemic control in patients with uncontrolled Type 2 Diabetes Methods: In a parallel group, single-blind randomised controlled study type 2 diabetic patients, with greater than 7% glycated haemoglobin (A1C) were randomised into intervention and usual care groups and followed for six months. Glycated haemoglobin analyzer, lipid analyzer and blood pressure monitor/apparatus were used to measure patients’ laboratory parameters at baseline and six months. Intervention group patients received pharmacist-structured care, made up of patient education and phone calls, in addition to usual care. In an intention to treat analysis, Mann-Whitney U test was used to compare median change at six months in the primary (A1C) and secondary outcome measures. Effect size was computed and proportion of patients that reached target laboratory parameters were compared in both arms. Results: All enrolled participants (108) completed the study 54 in each arm. Mean age was 51 (SD 11.75) and majority were females (68.5%). Participants in the intervention group had significant reduction in A1C of -0.75%, compared with an increase of 0.15% in the usual care group (p<0.001; eta-square= 0.144). The proportion of those that achieved target A1C of <7% at 6 months in the intervention and usual care group was 42.6% vs 20.8% (p=0.02). Furthermore, intervention patients were about 3 times more likely to have better glucose control; A1C<7% (a OR 2.72, 95%CI: 1.14-6.46) compared to usual care group, adjusted for sex, age, and duration of diabetes. Conclusions: Pharmacist-led care significantly improved glycaemic control in patients with uncontrolled T2DM.en_US
dc.description.sponsorshipACE: Drug Research, Herbal Medicine Development and Regulatory Scienceen_US
dc.identifier.issn1886-3655
dc.identifier.issn1885-642X
dc.identifier.urihttp://hdl.handle.net/123456789/1729
dc.language.isoenen_US
dc.publisherPharmacy Practiceen_US
dc.relation.ispartofseriesPharmacy Practice;2021 Jul-Sep;19(3)
dc.subjectType 2en_US
dc.subjectGlycemic Controlen_US
dc.subjectDiabetes Mellitusen_US
dc.subjectPharmacistsen_US
dc.subjectPharmaceutical Servicesen_US
dc.subjectBlood Glucoseen_US
dc.subjectRandomized Controlled Trials as Topicen_US
dc.subjectGlycated Hemoglobin Aen_US
dc.subjectIntention to Treat Analysisen_US
dc.subjectUniversity of Lagosen_US
dc.subjectACEDHARSen_US
dc.subjectACE: Drug Research, Herbal Medicine Development and Regulatory Scienceen_US
dc.titleImpact of pharmacist-led care on glycaemic control of patients with uncontrolled type 2 diabetes: a randomised controlled trial in Nigeriaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Impact of pharmacist-.pdf
Size:
908.21 KB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Health